Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Niagen, Niagen, Niagen · 1 trial · 1 indication
24 hour dosing period; 3 dosing periods each separated by 7 day washout
| Arm | Type | Description |
|---|---|---|
| Niagen 100mg | EXPERIMENTAL | 1 Niagen capsule (1 x 100 mg capsule) and 9 Placebo capsules |
| Niagen 300mg | EXPERIMENTAL | 3 Niagen capsules (3 x 100mg capsule) and 7 Placebo capsules |
| 1000mg Niagen | EXPERIMENTAL | 10 Niagen capsules (10 x 100mg capsule) |
| Name | Type | Description |
|---|---|---|
| Niagen 100mg | DIETARY_SUPPLEMENT | - |
| Niagen 300mg | DIETARY_SUPPLEMENT | - |
| Niagen 1000mg | DIETARY_SUPPLEMENT | - |
Inclusion Criteria: * Healthy Male or female age 30-55 years * BMI 18.5-29.9 kg/m2 * If female, subject is not of child bearing potential, OR Females of childbearing potential must agree to use a medically approved method of birth control and have a negative urine pregnancy test result. * Healthy a...